Ann: Response to ASX Aware Query, page-6

To be honest, I am not totally convinced that cannabis will be the future choice in pharmaceuticals.

Lots of hype around the product 5 years ago - and all cannabis stocks peaked at that time. Most have now gone well back from their highs. I believe cannabis in medicine has had its day and whatever benefits it brings now into the arena will largely be the limit.

MXC was excellent at self promotion - but rarely accurate. It is difficult to see their pipelines amounting to anything substantial - and their current financial position can only be described as precarious.

I never give advice to others to buy or sell shares in any company - and I won't start now. However, for those who do hold, I think the time has come to look at your investment in MXC very closely with balanced and an unemotional eye. MXC is looking a little shaky. If you do have queries, then push the company for answers - you don't know how long the opportunity to do so will last.